Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2006/137466
Kind Code:
A1
Abstract:
Disclosed is a pharmaceutical composition comprising, as an active ingredient, (-)-6-[3-[3-cyclopropyl-3-[(1R,2R)-2-hydroxycyclohexyl] ureido]-propoxy]-2-(1H)-quinoline which has pharmacological effects such as excellent anti-thrombotic effect and vascular neointimal formation-inhibiting effect and exhibiting an excellent property of eluting the active ingredient. A pharmaceutical composition comprising granules prepared from a mixture of hydroxypropylmethylcellulose and/or hydroxypropylcellulose in the powdery form and (-)-6-[3-[3-cyclopropyl-3-[(1R,2R)-2-hydroxycyclohexyl] ureido]-propoxy]-2-(1H)-quinoline in the powdery form.

Inventors:
SHIMOKAWA TATSUHARU (JP)
MINAMIZONO AKITO (JP)
TANIZAWA YOSHIO (JP)
Application Number:
PCT/JP2006/312470
Publication Date:
December 28, 2006
Filing Date:
June 22, 2006
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KOWA CO (JP)
SHIMOKAWA TATSUHARU (JP)
MINAMIZONO AKITO (JP)
TANIZAWA YOSHIO (JP)
International Classes:
A61K31/47; A61K9/16; A61K47/38; A61P7/02; A61P9/10
Domestic Patent References:
WO2002043704A12002-06-06
WO2003097102A12003-11-27
Foreign References:
JPH09157258A1997-06-17
JP2003073274A2003-03-12
JP2002167327A2002-06-11
JP2005139085A2005-06-02
Attorney, Agent or Firm:
SIKs & Co. (Kyobashi-Nisshoku Bldg. 8-7, Kyobashi 1-chome, Chuo-k, Tokyo 31, JP)
Download PDF: